wujia yizhi granules (KH110) / Chengdu Kanghong Pharma 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
wujia yizhi granules (KH110) / Chengdu Kanghong Pharma
NCT06534723: Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)

Recruiting
3
570
RoW
Wujia Yizhi granules, Placebo
Sichuan Jishengtang Pharmaceutical Co., Ltd.
Alzheimer's Dementia
08/26
12/26

Download Options